Learning Objectives CMS Measures in HF: 30-day Hospital Readmission Rates.

Slides:



Advertisements
Similar presentations
Kelley M. Anderson, PhD, FNP
Advertisements

West Lothian Community Health and Care Partnership Frail Elderly Programme Introduction – Marion Christie, Head of Health Data Label : Internal.
Home Health Remote Patient Monitoring For Heart Failure
Tsegazaab T. Weldegebrial Masters in Health Informatics
Community hospitals (1)
Interdisciplinary Team Role Play
Rate of 30-day hospital readmissions per 1,000 Medicare beneficiaries
Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.
Emerging Concepts in Heart Failure
Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF
Online Gifts Buy for wishes happy mother's day to yours choice and with happy gifts find here:
Monitoring Continuum ISSUE-3 Atrial Fibrillation Classification.
Current State of Hyperkalemia Management
Cardiac Troponin.
Acute Heart Failure.
A Paradigm Shift in PAH.
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Heart Failure and Hospital Readmissions
Heart Rate, HF Admissions, and Readmissions
The ABCs of AF.
NOACs in Clinical Practice: Are They All the Same?
Diagnostic Algorithms for ACS and High-Sensitivity Troponin
New Strategies to Prevent CV Events After Hospital Discharge
Hospitalizations in the United States Caused by ACS.
Biomarkers in Heart Failure
HHFMA Update with the Experts Benchmark of the Month:
Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.
Heart Failure Management Coordinated Care Approaches
Integrating Epilepsy Performance Measures Into Clinical Practice
Heart Failure Prevention: Mission Impossible?
Part I: A Sensible Approach to Sensitive Troponin
Learning Objectives Current Practices in Ruling Out AMI.
Exploring Emerging Treatments for Hyperkalemia
Preventing Heart Failure Readmission and Progression
Rheumatoid Arthritis 2015 Guidelines What's New? What's Different?
Advancing Acute Coronary Syndrome Assessment:
Remote Patient Management:
Evaluating New Therapies in HF
Heart Failure Hospitalization Risks with DPP-IV Inhibitors: Myth or Reality?
Using Heart Rate as a Biomarker in Clinical Practice.
Multidisciplinary Management of Hyperkalemia:
Overcoming Clinical Inertia
Updates in Heart Failure:
Revisiting the Pharmacoeconomics of HF
Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Heart Failure. Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure.
New Strategies to Reduce HF Readmissions
[Hospital/Facility Name/Logo]
Transitional Care of Patients With Hepatic Encephalopathy
Current Controversies and Advances in Hepatorenal Syndrome
Program Goals Background: Anticoagulation in Patients With VTE.
Improving Adherence to Antiplatelet Therapy After an ACS Event
Assessing the Burden of Hyperkalemia
The ABCs of AF.
Selecting Treatment Approaches in Hemophilia
What is “AF Burden”?. What is “AF Burden”? AF Burden and Stroke Risk ASSERT Study.
Contemporary Considerations in Biomarker-Guided Therapy
Nat. Rev. Cardiol. doi: /nrcardio
HF-Related Hospitalization and Readmissions
Assessing the Burden of Hyperkalemia
AHF Epidemiology Readmissions Reduction Program.
In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?
My PAH Patient.
Key Data on Improving Outcomes in HF Patients
QUALITY: COORDINATED CARE
Rethinking Risk Stratification for Nonischemic HF:
Treating Pulmonary Embolism Today
Presentation transcript:

Learning Objectives

CMS Measures in HF: 30-day Hospital Readmission Rates

The Rule

Hospitals Facing Readmissions Penalties

HFSA 2010 Practice Guideline Acute HF: Table 12.7. Discharge Criteria

Same-Day Access Clinic Reduces Readmissions at Duke

Geriatrics and HF

Remote Monitoring

Proportions of Readmissions for Causes Other Than the Condition at Initial Discharge

The Problem With the Metric

Omecamtiv Mecarbil - A Novel Selective Cardiac Myosin Activator

Serelaxin RELAX-AHF

PARADIGM-HF Study Design

Take-home Points and Summary

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)